Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 9th Annual Event in the Drug Discovery & Development Virtual Event ...

The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds—those with high ...

Academic scientists and pharmaceutical companies alike are embracing artificial intelligence, even as questions linger about ...

Genomics, a science-led techbio company using large-scale genetic information to develop innovative precision healthcare ...

This article is based on a poster originally authored by Peter Hsueh, Lili Qin, Jane Liu and Wenlin Ren. Target proteins are central to the antibody discovery process. These reagents play a critical ...

U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda ...

The drug discovery landscape is rapidly evolving with the integration of new technologies and methodologies. Returning for 2025, this event will focus on small molecule and biologic drug development, ...

A drug for pulmonary fibrosis created using artificial intelligence (AI) is showing early promise in patients.

Researchers at Harvard Medical School developed a tool that could use artificial intelligence to accelerate drug discovery ...

Protai, a structural-proteomics & AI driven biotech, has announced the addition of three leading scientists to its advisory ...